PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

A unified database for veterinary drugs will be launched in EAEU countries

The Collegium of the Eurasian Economic Commission (EEC) has approved the creation of a unified database for animal drugs identified through state supervision. This database will include information about quality, substandard, counterfeit, and falsified veterinary drugs within the territory of the Eurasian Economic Union (EAEU) member states.

New participants will join this process according to the procedure established by the Collegium’s decision No. 69 from May 30, 2023. The decision will come into effect on April 12.

In March 2024, new regulations for the circulation of veterinary drugs within the customs territory of the Eurasian Economic Union came into force. The document, approved by the EEC Council in January 2022, introduced unified requirements for the regulation of veterinary medicines; the registration procedures for these drugs and related procedures; the procedures for assessing the quality, safety, and effectiveness of veterinary products; and the criteria for their evaluation.

Additionally, it provides for a format of informational interaction in the exercise of state control over veterinary drugs circulation, as well as the registers and information databases of the EAEU in the field of veterinary medicines.

Source: GxP news, March 25, 2025.

Current news

  • July 7, 2025

    PharmEco to Launch Oncology Drug Production with ₽9.1 Billion Investment

    The PharmEco Group of Companies will build a pharmaceutical manufacturing facility for oncology treatments in…

  • July 7, 2025

    Russian Government Introduces New Procedure for Releasing Medicines into Civil Circulation

    The Russian government has approved updated regulations governing the release of medicines into civil circulation.…

  • July 7, 2025

    National Preference Benefits Will Now Apply to All Russian-Made Medicines, Not Just Those on the Vital Drugs List

    The Russian government has amended its decree on measures for granting national treatment in the…

  • July 7, 2025

    Medicine Sales in Russia Surpass 1 Trillion Rubles Since Beginning of the Year

    From January to April 2025, medicine sales in Russia reached 1.03 trillion rubles. Compared to…

  • July 7, 2025

    Pfizer CEO Proposes a “Pharmaceutical NATO” with Fixed Spending on Medicines

    Pfizer CEO Albert Bourla has called on European countries to increase their spending on medicines.…

LLC “BioJet”. all rights reserved

  • Legal information